Abiopharma

Silence Therapeutics Announces Leadership Changes

Silence Therapeutics Announces Leadership Changes

(99% Neutral) Spruce Biosciences, Inc. (SPRB) Announces New Board Appointment

Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

New Form S-4/A - BIOCRYST PHARMACEUTICALS INC Filed: 2025-12-15 AccNo: 0001140361-25-045461 Size: 4 MB

(99% Neutral) PASITHEA THERAPEUTICS CORP. (KTTAW) Announces Update on Collaboration with PASITHEA THERAPEUTICS CORP

Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission

(99% Positive) Quipt Home Medical Corp. (QIPT) Reports Q4 2025 Financial Results

(99% Neutral) RELMADA THERAPEUTICS, INC. (RLMD) Announces Executive Departure

New Form 10-K - Quipt Home Medical Corp. Filed: 2025-12-15 AccNo: 0001104659-25-120879 Size: 11 MB

(99% Neutral) Trinseo PLC (TSE) Announces Business Combination

New Form DEFA14A - Quipt Home Medical Corp. Filed: 2025-12-15 AccNo: 0001104659-25-120874 Size: 1 MB

(99% Neutral) Quipt Home Medical Corp. (QIPT) Announces Business Combination

Perimeter Solutions Announces Proposed Offering of $550 Million Senior Secured Notes